Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1

Status

Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Genitourinary 1

Conditions

Lung Neoplasms 21Breast Neoplasms 18Hematologic Neoplasms 16Colorectal Neoplasms 12Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 9Anatomic Stage I Breast Cancer AJCC v8 9Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Multiple Myeloma 5Leukemia, Myeloid, Acute 5Head and Neck Carcinoma 5Breast Carcinoma In Situ 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Carcinoma, Renal Cell 4Rectal Neoplasms 3Myelodysplastic Syndromes 3Mouth Neoplasms 3Malignant Solid Neoplasm 3Lymphoma 3Head and Neck Neoplasms 3

Interventions

Standard of Care 8Hydroxychloroquine 4BNT162 Vaccine 4Practice Guidelines as Topic 3Blood Specimen Collection 32019-nCoV Vaccine mRNA-1273 3tocilizumab 2sotrovimab 2cilgavimab and tixagevimab drug combination 2Specimen Handling 2Sodium Chloride 2CVnCoV COVID-19 vaccine 2COVID-19 Vaccines 2COH04S1 COVID-19 vaccine 2Azithromycin 2sinovac COVID-19 vaccine 1selinexor 1remdesivir 1proxalutamide 1palbociclib 1ogalvibart 1monalizumab 1lenzilumab 1crexavibart 1ciclesonide 1bemcentinib 1avdoralimab 1acalabrutinib 1XAV-19 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × COVID-19 × Practice Guidelines as Topic × Clear all
NCT04565665 2026-05-20

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
65 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT05102656 2026-05-20

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

M.D. Anderson Cancer Center

Phase NA Active not recruiting
107 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Emory University

Phase 3 Withdrawn
Genitourinary

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡